Management of XXXX in Canada in 2014.

@entity8974 @entity6923 @entity2380 @entity36018 @entity6313 @entity29444 @entity325 @entity2059
BACKGROUND: @entity6313 has several clinical presentations and is caused by various infectious organisms. OBJECTIVE: To provide guidance for selection of appropriate treatment. METHODS: The literature on @entity6313 management was reviewed to generate an evidence-based decision tree. RESULTS AND CONCLUSION: Several options are available: @entity8974 , @entity2059 , @entity2380 , @entity29444 8% nail lacquer, @entity36018 10% nail solution, and laser therapy. Further studies on lasers are needed before use can be recommended. Nondermatophyte molds or @entity325 can be managed with @entity8974 or @entity2059 with or without topicals. @entity2059 , @entity2380 , and @entity36018 can be used for @entity6923 . For dermatophytes, topicals can be considered for mild to moderate @entity6313 . For moderate to severe cases, any oral monotherapy can be used; however, we suggest @entity8974 if there is a possibility of a drug interaction. These recommendations can be applied for all ages, immune function, or metabolic status, but proper monitoring and contraindications should be taken into consideration.
